CENTER OF BIOMEDICAL RESEARCH EXCELLENCE (COBRE)

卓越生物医学研究中心 (COBRE)

• 批准号: 8172958
• 负责人: Konstantin G Kousoulas
• 金额: $ 6.18万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-05-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172958
• 关键词: Antigens; Centers of Research Excellence; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Immunoglobulin A; Infection; Institution; Mycobacterium tuberculosis; Pilot Projects; Regulon; Research; Research Personnel; Resources; Source; Tuberculosis; United States National Institutes of Health; immunopathology; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. During the last year the TNPRC Portion of the COBRE has consisted of 1) a major project to Dr. Kaushal, 2) a pilot project to Dr. Bapi Pahar and 3) a major project to Dr. Pahar that began when his pilot project ended. Lastly, Dr. Cristian Apetrei and Andrew MacLean who "graduated" from the COBRE continue to be involved in the COBRE. Dr. Kaushal's project is entitled: Mycobacterium tuberculosis sigma H and its regulon in the immunopathology of Tuberculosis. Dr. Pahar's project is entitled: Importance of antigen specific IgA responses in controlling SIV/SHIV infection.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 去年，COBRE 的 TNPRC 部分包括 1) Kaushal 博士的一个主要项目，2) Bapi Pahar 博士的一个试点项目，3) Pahar 博士的一个主要项目，该项目在他的试点项目结束后开始。 最后，从 COBRE“毕业”的 Cristian Apetrei 博士和 Andrew MacLean 博士继续参与 COBRE。 Kaushal 博士的项目标题为：结核分枝杆菌 sigma H 及其在结核病免疫病理学中的调节子。 Pahar 博士的项目标题为：抗原特异性 IgA 反应在控制 SIV/SHIV 感染中的重要性。